Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study

OBJECTIVE: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naïve patients with branch retinal vein occlusion (BRVO) enrolled in the LUMINOUS(™) study. STUDY DESIGN: A 5-year, global, prospective, multicenter, observational, open-label study conducted...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Pearce, Ian, Clemens, Andreas, Brent, Michael H., Lu, Lin, Gallego-Pinazo, Roberto, Minnella, Angelo Maria, Creuzot-Garcher, Catherine, Spital, Georg, Sakamoto, Taiji, Dunger-Baldauf, Cornelia, McAllister, Ian L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302470/
https://ncbi.nlm.nih.gov/pubmed/32555630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0234739
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia